Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Up 1,312.5% in January

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 33,900 shares, an increase of 1,312.5% from the December 31st total of 2,400 shares. Approximately 1.2% of the company’s stock are sold short. Based on an average daily volume of 1,090,000 shares, the days-to-cover ratio is presently 0.0 days.

Shuttle Pharmaceuticals Price Performance

Shares of NASDAQ SHPH traded down $0.05 during midday trading on Tuesday, hitting $0.80. The company’s stock had a trading volume of 25,371 shares, compared to its average volume of 88,410. The company’s fifty day moving average price is $0.82. Shuttle Pharmaceuticals has a 1 year low of $0.58 and a 1 year high of $4.71. The stock has a market capitalization of $3.26 million, a price-to-earnings ratio of -0.19 and a beta of -1.74.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .